IFx-2.0, an innate immune agonist, targets resistance to immune checkpoint inhibitors in advanced cutaneous melanoma, receiving FDA orphan drug designation. Phase 1 trials showed IFx-2.0's safety and ...
The internet star died on Dec. 11, five years after she was first diagnosed with a recurring form of neuroblastoma cancer ...
We recently compiled a list of the 20 Best Biotech Stocks Under $20 to Buy Now. Amicus Therapeutics, Inc. tops our list for ...
OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or “the Company”), the world leader in listeria-based cancer ...
Everyone knows actor Choi Woo-shik from the Oscar-sweeping sensation "Parasite." His Ki-woo was the crafty son who hatched ...
NEW YORK, NY; NEW HAVEN, CT; PRINCETON, NJ, and TAIPEI, TAIWAN, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ...
Flaky pie, hot coffee, and zero rush. This small-town Illinois café turns “just one slice” into a very optimistic plan.
In a study published in Nature on January 28, a research team led by Eric H. Xu (XU Huaqiang) from the Shanghai Institute of Materia Medica of the ...
A Knight Of The Seven Kingdoms just released its best episode yet, rivaling some of the best of Game Of Thrones.
Mark Quarmby was 'having issues with his Universal Credit' ...
Woody gave her prediction during an annual celebration at Howell Nature Center on Feb. 2. Woody has been sharing her ...
The majority (57.5 percent) of commercially insured patients had at least one chronic condition in 2024. The average allowed amount1 for a patient with no chronic conditions was $1,590, while the ...